FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2038419425> ?p ?o ?g. }

• W2038419425 endingPage "3308" @default.
• W2038419425 startingPage "3304" @default.
• W2038419425 abstract "Growth rate inhibition of subcutaneously implanted tumors results from feeding rats and athymic nude mice diets containing 1% cyclocreatine or 1%, 2%, 5%, or 10% creatine. The tumors studied included rat mammary tumors (Ac33tc in Lewis female rats and 13762A in Fischer 344 female rats), rat sarcoma MCI in Lewis male rats, and tumors resulting from the injection of two human neuroblastoma cell lines, IMR-5 and CHP-134, in athymic nude mice. Inhibition was observed regardless of the time experimental diets were administered, either at the time of tumor implantation or after the appearance of palpable tumors. For mammary tumor Ac33tc, the growth inhibition during 24 days after the implantation was approximately 50% for both 1% cyclocreatine and 1% creatine, and inhibition increased as creatine was increased from 2% to 10% of the diet. For the other rat mammary tumor (13762A), there was approximately 35% inhibition by both 1% cyclocreatine and 2% creatine. In the case of the MCI sarcoma, the inhibitory effect appeared more pronounced at earlier periods of growth, ranging from 26% to 41% for 1% cyclocreatine and from 30% to 53% for 1% creatine; there was no significant difference in growth rate between the tumors in the rats fed 1% and 5% creatine. The growth rate of tumors in athymic nude mice, produced by implantation of the human neuroblastoma IMR-5 cell line, appeared somewhat more effectively inhibited by 1% cyclocreatine than by 1% creatine, and 5% creatine feeding was most effective. For the CHP-134 cell line, 33% inhibition was observed for the 1% cyclocreatine diet and 71% for the 5% creatine diet. In several experiments, a delay in appearance of tumors was observed in animals on the experimental diets. In occasional experiments, neither additive inhibited tumor growth rate for the rat tumors or the athymic mouse tumors." @default.
• W2038419425 created "2016-06-24" @default.
• W2038419425 creator A5011751620 @default.
• W2038419425 creator A5025927994 @default.
• W2038419425 creator A5076092473 @default.
• W2038419425 date "1993-04-15" @default.
• W2038419425 modified "2023-09-30" @default.
• W2038419425 title "Inhibition of rate of tumor growth by creatine and cyclocreatine." @default.
• W2038419425 cites W1482372955 @default.
• W2038419425 cites W1485881868 @default.
• W2038419425 cites W1488435846 @default.
• W2038419425 cites W1496717455 @default.
• W2038419425 cites W1502013298 @default.
• W2038419425 cites W1522079693 @default.
• W2038419425 cites W1555419083 @default.
• W2038419425 cites W1596901281 @default.
• W2038419425 cites W1639281371 @default.
• W2038419425 cites W1768364897 @default.
• W2038419425 cites W1914241072 @default.
• W2038419425 cites W1964511888 @default.
• W2038419425 cites W1975982125 @default.
• W2038419425 cites W2000372599 @default.
• W2038419425 cites W2002567781 @default.
• W2038419425 cites W2009198300 @default.
• W2038419425 cites W2018606154 @default.
• W2038419425 cites W2018978645 @default.
• W2038419425 cites W2023922395 @default.
• W2038419425 cites W2040810099 @default.
• W2038419425 cites W2045066046 @default.
• W2038419425 cites W2059502142 @default.
• W2038419425 cites W2071408149 @default.
• W2038419425 cites W2073363186 @default.
• W2038419425 cites W2091403786 @default.
• W2038419425 cites W2123345036 @default.
• W2038419425 cites W2409847547 @default.
• W2038419425 cites W2412371583 @default.
• W2038419425 cites W4301418850 @default.
• W2038419425 doi "https://doi.org/10.1073/pnas.90.8.3304" @default.
• W2038419425 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/46288" @default.
• W2038419425 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8475072" @default.
• W2038419425 hasPublicationYear "1993" @default.
• W2038419425 type Work @default.
• W2038419425 sameAs 2038419425 @default.
• W2038419425 citedByCount "67" @default.
• W2038419425 countsByYear W20384194252012 @default.
• W2038419425 countsByYear W20384194252013 @default.
• W2038419425 countsByYear W20384194252014 @default.
• W2038419425 countsByYear W20384194252015 @default.
• W2038419425 countsByYear W20384194252016 @default.
• W2038419425 countsByYear W20384194252017 @default.
• W2038419425 countsByYear W20384194252019 @default.
• W2038419425 countsByYear W20384194252020 @default.
• W2038419425 countsByYear W20384194252021 @default.
• W2038419425 countsByYear W20384194252022 @default.
• W2038419425 countsByYear W20384194252023 @default.
• W2038419425 crossrefType "journal-article" @default.
• W2038419425 hasAuthorship W2038419425A5011751620 @default.
• W2038419425 hasAuthorship W2038419425A5025927994 @default.
• W2038419425 hasAuthorship W2038419425A5076092473 @default.
• W2038419425 hasBestOaLocation W20384194251 @default.
• W2038419425 hasConcept C121608353 @default.
• W2038419425 hasConcept C126322002 @default.
• W2038419425 hasConcept C134018914 @default.
• W2038419425 hasConcept C142724271 @default.
• W2038419425 hasConcept C2776187077 @default.
• W2038419425 hasConcept C2776715637 @default.
• W2038419425 hasConcept C2778001805 @default.
• W2038419425 hasConcept C2778256501 @default.
• W2038419425 hasConcept C2779707156 @default.
• W2038419425 hasConcept C2779896295 @default.
• W2038419425 hasConcept C2780278673 @default.
• W2038419425 hasConcept C36880943 @default.
• W2038419425 hasConcept C530470458 @default.
• W2038419425 hasConcept C54355233 @default.
• W2038419425 hasConcept C55493867 @default.
• W2038419425 hasConcept C62112901 @default.
• W2038419425 hasConcept C71924100 @default.
• W2038419425 hasConcept C81885089 @default.
• W2038419425 hasConcept C86803240 @default.
• W2038419425 hasConceptScore W2038419425C121608353 @default.
• W2038419425 hasConceptScore W2038419425C126322002 @default.
• W2038419425 hasConceptScore W2038419425C134018914 @default.
• W2038419425 hasConceptScore W2038419425C142724271 @default.
• W2038419425 hasConceptScore W2038419425C2776187077 @default.
• W2038419425 hasConceptScore W2038419425C2776715637 @default.
• W2038419425 hasConceptScore W2038419425C2778001805 @default.
• W2038419425 hasConceptScore W2038419425C2778256501 @default.
• W2038419425 hasConceptScore W2038419425C2779707156 @default.
• W2038419425 hasConceptScore W2038419425C2779896295 @default.
• W2038419425 hasConceptScore W2038419425C2780278673 @default.
• W2038419425 hasConceptScore W2038419425C36880943 @default.
• W2038419425 hasConceptScore W2038419425C530470458 @default.
• W2038419425 hasConceptScore W2038419425C54355233 @default.
• W2038419425 hasConceptScore W2038419425C55493867 @default.
• W2038419425 hasConceptScore W2038419425C62112901 @default.
• W2038419425 hasConceptScore W2038419425C71924100 @default.
• W2038419425 hasConceptScore W2038419425C81885089 @default.
• W2038419425 hasConceptScore W2038419425C86803240 @default.

• next